Back to search

Article

Distinct medical and substance use histories associate with cognitive decline in Alzheimer’s Disease

2024-11-28

Abstract excerpt

<h4>INTRODUCTION</h4> Phenotype clustering reduces patient heterogeneity and could be useful when designing precision clinical trials. We hypothesized that the onset of early cognitive decline in patients would exhibit variance predicated on the clinical history documented prior to an Alzheimer’s Disease (AD) diagnosis <h4>METHODS</h4> Self-reported medical and substance use history (i.e., problem history) was use...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7641e0bb-bcb9-5ae4-9a06-3b95d42449e5
DOI
10.1101/2024.11.26.24317918
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Distinct medical and substance use histories associate with cognitive decline in Alzheimer’s DiseaseDOI 10.1101/2024.11.26.24317918
Select a neighboring publication to make it the new centre.